TOP2A and prostate cancer: The molecular mechanisms fueling prostate cancer pathogenesis remain relatively unknown15–19; however, topoisomerase II alpha (TOP2A), a nuclear enzyme involved in chromosome condensation and chromatid separation, has been shown to be upregulated with increasing Gleason score and with hormone insensitivity in prostate carcinoma20.